Gallagher patent opposition analysis

The comprehensive analysis of Gallagher opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Gallagher

Patent NumberTitleApplicantOpposition DateOpposition Company
Dual-Acting Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) InhibitorNOVARTISFeb 15, 2017TEVA PHARMACEUTICAL INDUSTRIES LTD
Tablets For Combination TherapyGILEAD SCIENCESApr 22, 2016TEVA PHARMACEUTICAL INDUSTRIES LTD

Top companies who are the clients of Gallagher